India to British Virgin Islands: Daratumumab Export Trade Route

The India to British Virgin Islands Daratumumab corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $54.6K USD. The route is dominated by VEA IMPEX (I) PRIVATE LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's daratumumab manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $7.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with daratumumab's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 11.4%, placing it at rank #10 among India's top daratumumab export destinations globally.

On the import side, key buyers of Indian daratumumab in British Virgin Islands include TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER OF INVOICE RAISED TO , TO THE ORDER OF- . TO THE ORDER OF INVOICE RAISED TO is the single largest importer with 3 shipments valued at $27.1K USD.

India's daratumumab exports to British Virgin Islands are driven primarily by a handful of large-scale manufacturers. VEA IMPEX (I) PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in British Virgin Islands benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VEA IMPEX (I) PRIVATE LIMITED, VEA IMPEX (I) PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $7.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as darzalex 400mg inj (20 ml) daratumumab and contain medicines harmless pharmaceutical products - darzalex 400mg inj (20 ml)daratumumab, suggesting that buyers in British Virgin Islands tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF INVOICE RAISED TO is the largest importer with 3 shipments worth $27.1K USD — representing 50% of all daratumumab imports from India on this route.